Page last updated: 2024-10-26

etilefrine and Obesity

etilefrine has been researched along with Obesity in 1 studies

Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pasquali, R1
Cesari, MP1
Besteghi, L1
Melchionda, N1
Balestra, V1

Other Studies

1 other study available for etilefrine and Obesity

ArticleYear
Thermogenic agents in the treatment of human obesity: preliminary results.
    International journal of obesity, 1987, Volume: 11 Suppl 3

    Topics: Adult; Ephedrine; Etilefrine; Female; Humans; Obesity; Phenylephrine

1987